DatasetName,CYB5R3_S(179) CYB5R3_S(71),CYB5R3_S(123) CYB5R3_S(146) CYB5R3_S(15) CYB5R3_Y(57),CYB5R3_S(38) CYB5R3_T(189),CYB5R3_S(3) CYB5R3_T(7)
RM2024_Intensity D4-1___3,,,,
RB2022_4_PostEndurance,,0.5267449659617792,,
FSO2013_Ratio M/L normalized Rep3,,,,
SR2019_MCF7_Biol_repl_3,,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,,
SR2019_LM2_Biol_repl_1,,,,
RCJD2014_15min_1,,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,,
CK2022_7 16-1,,,,
NJH2025_Sub12_HIIT_Mid,,,,
AH2018_LFQ_IT_1_C,,,,
RKK2015_TNF-α/basal,,,,
JJ2018_Ratio H/M normalized pP2,,,,
NJH2025_Sub12_MICT_Pre,,,,
NJH2025_Sub7_MICT_Post,,,,
DL2023_control-3,,,,
ZX2022_Control Replicate 2,,,0.3813145689810434,
HS2024_6_B_T3,,,,
JW2015_Intensity pre1,,,,
IMM2018_normalised rep. int. Empty-3,,,,
AMK2021_30R_p5,,,,
FSO2013_Ratio M/L normalized Rep1,,,,
SR2019_MDAMB231_Biol_repl_4,,,,
GF2025_P2_Sph,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,,
NJH2025_Sub13_HIIT_Mid,,,,
CP2009_Ratio M/L,,,,
NJH2025_Sub7_HIIT_Post,,,,
KBE2022_Log2_Ex_44_T,,,,
DB2022_Intensity L2,,,,
TM2022_mock.4h.C,,,,
AST2020_anti-CD3.2,,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,,
HS2024_7_B_N1,,,,
FSO2013_Ratio M/L normalized Rep1___1,,,,
SAS2015_AZD/DMSO_Exp3,,,,
RM2024_Intensity D0-2___3,,,,
RM2024_Intensity D6-1,,,,
RB2022_8_RecoverySprint,,0.5417872609232368,,
RB2022_5_PreEndurance,,0.5393988167862355,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,,
EP2017_Untreated R#4 normalized log2 ratio,,0.4977984758607235,,
WZ2023_Pu_010_30min,,,,
AS2011_Ratio H/L Proteins RNAi_2,,,,
RB2022_4_PreStrength,,0.5271873120214093,,
NJH2024_Sub4_MICT_Post,,,,
AH2018_LFQ_M_1_X,,,,
RB2022_8_RecoveryEndurance,,,,
KBE2022_Log2_Ex_14_U,,,,
FSO2013_Ratio M/L normalized Rep3___3,,,,
AH2018_TMTMS3_1_C,,,,
JJ2018_Ratio H/L normalized___1,,,,
ZQ2022_C2,,0.4990975561458335,0.48047484665400897,
RB2022_5_PreSprint,,,,
PG2020_Intensity 8h_C,,,,
AH2018_SILAC_MR_2_N,,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,,
TM2022_S2.8h.B,,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,,
RM2024_Intensity D6-1___2,,,,
NJH2025_Sub7_MICT_Mid,,,,
LY2019_P1+,,0.5058892847670322,,
AS2011_Ratio H/L Proteins Inhi_2,,,,
BS2014_Log2(Ratio H/L normalized),,,,
UK2020_HCM_2,,,,
FSO2013_Ratio H/L normalized Rep2___2,,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5038191426075396,,
RM2024_Intensity D4-3___3,,,,
RB2022_5_PreStrength,,0.5343740260174397,,
NJH2024_Sub4_MICT_Mid,,,,
TM2022_S2.4h.A,,,,
RB2022_5_PostStrength,,,,
GF2025_P6_Sph,,,,
RB2022_2_PreSprint,,0.5179848730809455,,
ZX2022_CB treated Replicate 3,,,0.375461912281978,
RM2024_Intensity D6-2___3,,,,
WZ2023_Pe_025_10min,,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,,
AST2020_anti-CD3+PDL2.1,,,,
KBE2022_Log2_Ex_34_U,,,,
WZ2023_Pu_005_10min,,,,
AS2011_Ratio H/L RNAi_2_1,,,,
NJH2024_Sub9_HIIT_Mid,,,,
CK2022_9 40-1,,,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,,
LG2023_GSK3α-1_intensity,,,,
WZ2023_Pu_025_30min,,,,
AH2018_SILAC_MR_2_X,,,,
HS2024_4_PD_T2,,,,
NJH2024_Sub4_HIIT_Pre,,,,
RB2022_2_RecoverySprint,,0.5221776357270762,,
AS2011_Ratio H/L Protein RNAi_1,,,,
RM2024_Intensity D2-1___2,,,,
CR2017_Ratio Replicate 1.4,,,,
FR2021_Norm.Intensity.B,,,,
RM2024_Intensity D6-2___1,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,,
RB2022_5_PostSprint,,0.5378703512957651,,
EJN2021_3_Rest_Basal,,0.5296296594302328,0.4168197797046129,
CR2017_Ratio Replicate 1.3,,,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,,
KTGR2014_Ratio-Rapa 7 mins,,,,
AMK2021_120R_p1,,,,
AH2018_SILAC_3_X,,,,
JJ2018_Ratio M/L normalized pP3,,,,
AH2018_SILAC_M_2_N,,,,
HS2024_7_PD_T2,,,,
FSO2013_Ratio H/L normalized Rep1___1,,,,
AH2018_LFQ_1_C,,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,,
KBE2022_Log2_Ex_28_T,,,,
HS2024_3_B_N1,,,,
RM2024_Intensity D4-2___3,,,,
WZ2023_Pe_025_30min,,,,
CK2022_11 40-1,,,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,,
AH2018_SILAC_2_X,,,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,,
AS2011_Ratio H/L RNAi_1_2,,,,
KS2014_Intensity E15_1,,,,
FSO2013_Ratio H/L normalized Rep2,,,,
WZ2023_Pu_005_20min,,,,
NJH2024_Sub10_MICT_Post,,,,
RM2024_Intensity D2-3___1,,,,
CR2017_Ratio Replicate 1.5,,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,,
HS2024_7_B_T3,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,,
AS2011_Ratio H/L RNAi_1,,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,,
AH2018_LFQ_M_1_C,,,,
NJH2025_Sub7_MICT_Pre,,,,
SR2019_SKBR3_Biol_repl_2,,,,
HS2024_9_B_T2,,,,
KTGR2014_Ratio-AA 7 mins,,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,,
HS2024_3_PD_T1,,,,
FSO2013_Ratio M/L normalized Rep3___2,,,,
SR2019_BT549_Biol_repl_3,,,,
RCJD2014_20min_mean,,,,
FR2021_Norm.Intensity.H,,,,
RB2022_2_PreStrength,,0.53454085908969,,
DB2022_LFQ intensity L1.2,,,,
HS2024_4_B_N1,,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,,
CK2022_1 16-1,,,,
CK2022_1 200-1,,,,
PG2020_Intensity Mock_10h_D,,,,
SR2019_MCF10A_Biol_repl_2,,,,
JJ2018_Ratio M/L normalized pP2___2,,,,
HS2024_6_PD_T1,,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,,
RB2022_6_RecoveryEndurance,,0.5162718805204793,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.5211951883896445,,
RCJD2014_5min_1,,,,
RM2024_Intensity D4-1___1,,,,
DL2023_24h-1,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,,
TM2022_S2.4h.C,,,,
SAS2015_PLX/AZD_Exp2,,,,
CR2017_Ratio Replicate 3.3,,,,
PG2020_Intensity 2h_C,,,,
VOI2024_Veh2 di,,,,
ZX2022_CB treated Replicate 2,,,0.3676038962571172,
KBE2022_Log2_Ex_8_T,,,,
NJH2025_Sub10_MICT_Post,,,,
HS2024_6_I_T3,,,,
RN2012_L11,0.4996844619836932,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,,
IMM2018_normalised rep. int. Empty-1,,,,
HS2024_5_PD_T1,,,,
AH2018_LFQ_M_2_C,,,,
CK2022_3 40-1,,,,
RBK2021_1260T Early,,,,
NJH2024_Sub4_HIIT_Post,,,,
HS2024_4_I_T1,,,,
YA2020_Reporter_intensity_Cancer_No.5,,,,
HH2022_Reporter intensity 8,,,,
ZQ2022_N2,,0.555027880509647,0.4915013297545674,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,,
FSO2013_Ratio H/L normalized Rep3___3,,,,
AH2018_TMTMS3_2_N,,,,
EJN2021_5_Rest_Basal,,0.5316107322420459,0.40888600060627195,
NJH2025_Sub2_HIIT_Post,,,,
NJH2025_Sub1_MICT_Post,,,,
HS2024_9_B_T1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,,
JAW2011_Ratio H/L LS2_1,,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,,
NJH2024_Sub6_HIIT_Pre,,,,
AH2018_SILAC_3_N,,,,
YA2020_Reporter_intensity_Normal_No.1,,,,
HS2024_3_B_T1,,,,
JJ2018_Ratio H/L normalized___2,,,,
RM2024_Intensity D0-2,,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,,
RB2022_7_PostStrength,,0.5325443886150956,,
RB2022_1_PostEndurance,,0.5464823964284925,,
CR2017_Ratio Replicate 3,,,,
SR2019_Hs578T_Biol_repl_3,,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,,
RBK2021_1244T Early,,,,
RB2022_3_PostSprint,,0.4891851750725203,,
NJH2024_Sub13_MICT_Mid,,,,
KTGR2014_Ratio-AA 2 mins,,,,
GF2025_P7_Sph,,,,
HS2024_8_I_T3,,,,
CF2017_EOC 3,,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,,
HS2024_6_PD_T3,,,,
DL2023_12h-2,,,,
RM2024_Intensity D6-3___1,,,,
FS2019_Ctr1,,,,
WZ2023_Pu_010_20min,,,,
AS2011_Ratio H/L_3,,,,
CK2022_1 40-1,,,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,,
CK2022_8 16-1,,,,
KS2014_Intensity N3,,,,
RB2022_4_RecoveryEndurance,,0.5168830819721147,,
RB2022_5_RecoveryEndurance,,0.5156118457589753,,
JAW2011_Ratio H/L LS1a_2,,,,
NJH2024_Sub12_HIIT_Mid,,,,
AH2018_LFQ_IT_1_N,,,,
FSO2013_Ratio H/M normalized Rep2,,,,
RAM2015_Log2 A,,,,
HS2024_8_PD_T1,,,,
JJ2018_Ratio H/L normalized pP2,,,,
CF2017_OSE 27,,,,
KS2014_Intensity E15_2,,,,
BS2014_Log2(Ratio H/L protein),,,,
PG2020_Intensity 8h_A,,,,
HS2024_7_I_T1,,,,
VOI2024_Veh3 di,,,,
RKK2015_TNF-α+SC-514/basal,,,,
SR2019_JIMT1_Biol_repl_1,,,,
HW2015_Ratio H/L normalized Exp2,,,,
HS2024_3_I_N1,,,,
AH2018_SILAC_M_3_X,,,,
NJH2024_Sub9_HIIT_Post,,,,
AS2011_Ratio H/L RNAi_1_3,,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,,
NJH2025_Sub1_HIIT_Pre,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,,
NJH2024_Sub4_HIIT_Mid,,,,
VOI2024_0.1uM 2 h_1 di,,,,
KBE2022_Log2_Ex_6_T,,,,
RM2024_Intensity D4-3___1,,,,
AH2018_LFQ_4_X,,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,,
RB2022_8_PostEndurance,,0.5563372668670321,,
NJH2025_Sub4_MICT_Mid,,,,
YP2020_Intensity C30_R1_mult_log2,,,,
AST2020_anti-CD3.1,,,,
NJH2025_Sub4_HIIT_Post,,,,
EP2017_Untreated R#4 log2 ratio,,0.49722623440472824,,
HS2024_6_B_N1,,,,
KBE2022_Log2_Ex_27_T,,,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,,
VOI2024_0.1uM 24 h_1 mono,,,,
AMK2021_120R_p5,,,,
AS2011_Ratio H/L Proteins,,,,
NJH2024_Sub7_HIIT_Post,,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,,0.5256823098646342
AS2011_Ratio H/L RNAi_2_2,,,,
RB2022_7_RecoveryStrength,,0.5052165720914411,,
AH2018_SILAC_IT_3_X,,,,
JAW2011_Ratio H/L,,,,
PG2020_Intensity 10h_C,,,,
FSO2013_Ratio M/L normalized Rep2,,,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,,
HH2022_Reporter intensity 5,,,,
SR2019_HCC1954_Biol_repl_2,,,,
CK2022_14 40-1,,,,
RB2022_6_PreSprint,,0.5131006316540331,,
NJH2025_Sub12_MICT_Mid,,,,
PG2020_Intensity 4h_D,,,,
NJH2025_Sub2_MICT_Post,,,,
AH2018_LFQ_4_C,,,,
DL2023_control-1,,,,
AR2021_ALG 10 μM,,,,
JAW2011_Ratio H/L LS2_2,,,,
AH2018_SILAC_IT_3_N,,,,
EJN2021_4_Rest_Ins,,0.5198845988188661,0.4033263991474,
RN2012_H05,0.4536976264470819,,,
NJH2024_Sub7_HIIT_Mid,,,,
GF2025_P2_Adh,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,,
RB2022_8_PostSprint,,0.5383888206257605,,
EJN2021_1_Rest_Ins,,0.522787751925577,0.4501994050489932,
HH2022_Reporter intensity 3,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,,
AH2018_SILAC_IT_1_C,,,,
JW2021_After_3,,,,
GF2025_P8_Sph,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,,
JJ2018_Ratio M/L normalized pP2___1,,,,
AH2018_SILAC_2_N,,,,
CK2022_11 200-1,,,,
CK2022_12 200-1,,,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,,
RM2024_Intensity D2-1___3,,,,
NJH2024_Sub1_MICT_Pre,,,,
HH2022_Reporter intensity 9,,,,
WZ2023_Su_010_20min,,,,
AH2018_TMTMS2_2_N,,,,
NJH2024_Sub13_MICT_Pre,,,,
KBE2022_Log2_Ex_41_U,,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,,0.5631969424233496
AH2018_TMTMS3_Pool,,,,
KS2014_Intensity N4,,,,
NJH2024_Sub1_HIIT_Post,,,,
MM2018_Ratio H/L replicate2,,,,
RM2024_Intensity D4-2___2,,,,
NJH2024_Sub13_HIIT_Pre,,,,
CF2017_OSE 26,,,,
CK2022_14 200-1,,,,
SR2019_Hs578T_Biol_repl_1,,,,
RB2022_7_PostSprint,,0.5194662643223208,,
TM2022_mock.4h.A,,,,
NJH2025_Sub12_HIIT_Pre,,,,
AH2018_TMTMS3_1_N,,,,
AST2020_anti-CD3+PDL2.2,,,,
PG2020_Intensity Mock_10h_A,,,,
JW2021_After_2,,,,
NJH2024_Sub2_MICT_Post,,,,
EJN2021_2_Rest_Ins,,0.5211684816589011,0.44742323996842115,
SR2019_LM2_Biol_repl_4,,,,
CP2009_Ratio H/M,,,,
JAW2011_Ratio H/L HS,,,,
CK2022_13 16-1,,,,
GF2025_P1_Adh,,,,
GF2025_P1_Sph,,,,
EJN2021_5_Ex_Basal,,0.5256570538008934,0.42754388225338313,
HS2024_7_I_T3,,,,
JJ2018_Ratio H/L normalized pP2___2,,,,
WZ2023_Pe_010_10min,,,,
CF2017_EOC 1,,,,
CK2022_3 200-1,,,,
AH2018_LFQ_IT_3_C,,,,
SR2019_Hs578T_Biol_repl_2,,,,
NJH2024_Sub12_HIIT_Post,,,,
JJ2018_Ratio H/L normalized pP1___2,,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,,
NJH2024_Sub10_MICT_Mid,,,,
NJH2024_Sub13_MICT_Post,,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,,
RB2022_3_RecoverySprint,,0.5177141522089834,,
NJH2025_Sub1_HIIT_Mid,,,,
RCJD2014_20min_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,,
HS2024_6_PD_T2,,,,
HS2024_5_B_T1,,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,,
DL2023_12h-3,,,,
SR2019_MDAMB231_Biol_repl_2,,,,
HS2024_3_B_T2,,,,
RB2022_6_PreStrength,,0.5273695569149681,,
CK2022_2 40-1,,,,
RB2022_1_PostSprint,,0.5196576356990372,,
CK2022_4 200-1,,,,
JW2021_Before_2,,,,
TM2022_S2.12h.A,,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,,
CK2022_5 16-1,,,,
AR2021_ALG 1 μM,,,,
HS2024_4_B_T1,,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,,
SR2019_BT549_Biol_repl_4,,,,
EJN2021_1_Rest_Basal,,0.5270306191019101,0.45594616532577936,
NJH2025_Sub8_MICT_Post,,,,
RCJD2014_5min_3,,,,
CR2017_Ratio Replicate 3.2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,,
GF2025_P7_Adh,,,,
CK2022_9 16-1,,,,
NJH2024_Sub6_HIIT_Post,,,,
AMK2021_30R_p3,,,,
AS2011_Ratio H/L Normalized RNAi_2,,,,
RM2024_Intensity D0-2___2,,,,
KS2014_Intensity pY_N4,,,,
CK2022_13 200-1,,,,
AS2011_Ratio H/L Normalized_2,,,,
PG2020_Intensity 6h_D,,,,
CK2022_16 16-1,,,,
FS2019_db/db3,,,,
CK2022_15 40-1,,,,
NJH2024_Sub9_MICT_Pre,,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,,
WZ2023_Su_005_10min,,,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,,
KBE2022_Log2_Ex_41_T,,,,
AMK2021_Ctrl_p1,,,,
AH2018_LFQ_IT_3_X,,,,
HS2024_5_PD_T3,,,,
AH2018_TMTMS3_3_X,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,,
KBE2022_Log2_Ex_40_U,,,,
AH2018_LFQ_M_1_N,,,,
KBE2022_Log2_Ex_27_U,,,,
HW2015_Ratio M/L normalized Exp3,,,,
RKK2015_TNF-α/IKKb(K44M),,,,
AH2018_SILAC_M_1_N,,,,
HW2015_Ratio M/L normalized Exp1,,,,
RB2022_5_RecoveryStrength,,0.512950392302674,,
YP2020_Intensity P10_R1_mult_log2,,,,
RB2022_7_PreStrength,,0.5342812172355907,,
YA2020_Reporter_intensity_Normal_No.4,,,,
NJH2025_Sub13_HIIT_Pre,,,,
PG2020_Intensity CT_D,,,,
NJH2025_Sub9_MICT_Post,,,,
VOI2024_Veh1 mono,,,,
CK2022_12 16-1,,,,
RN2012_L13,0.49136286697892423,,,
LG2023_Control-1_intensity,,,,
RM2024_Intensity D6-3___2,,,,
KBE2022_Log2_Ex_8_U,,,,
SR2019_SKBR3_Biol_repl_3,,,,
NJH2024_Sub1_MICT_Post,,,,
HS2024_3_I_T2,,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,,
RM2024_Intensity D0-3___3,,,,
HS2024_6_I_T2,,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,,
AS2011_Ratio H/L Protein Inhi_1,,,,
FSO2013_Ratio H/M normalized Rep2___1,,,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,,
CK2022_10 40-1,,,,
NJH2024_Sub12_HIIT_Pre,,,,
NJH2024_Sub8_MICT_Pre,,,,
RM2024_Intensity D0-1___1,,,,
LY2019_P3+,,0.5456170714893619,,
HH2022_Reporter intensity 6,,,,
RB2022_2_RecoveryStrength,,0.5217497522679198,,
KTGR2014_Ratio-AA 15 mins,,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,,
KS2014_Intensity pY_N3,,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,,
LY2019_P5-,,0.5095719238607925,,
HW2015_Ratio M/L normalized Exp2,,,,
SR2019_HCC1419_Biol_repl_1,,,,
AH2018_TMTMS2_3_X,,,,
GF2025_P3_Adh,,,,
SR2019_JIMT1_Biol_repl_2,,,,
AH2018_TMTMS2_1_C,,,,
RM2024_Intensity D0-1___2,,,,
LY2019_P4+,,0.5680946220870952,,
KBE2022_Log2_Ex_19_U,,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,,
RB2022_4_PostStrength,,0.5279242361969881,,
LG2023_GSK3α-3_intensity,,,,
YA2020_Reporter_intensity_Cancer_No.1,,,,
AST2020_Control,,,,
JAW2011_Ratio H/L LS1a,,,,
RCJD2014_5min_mean,,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,,
NJH2025_Sub1_MICT_Mid,,,,
TM2022_S2.12h.C,,,,
NJH2025_Sub9_MICT_Mid,,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,,
FSO2013_Ratio M/L normalized Rep2___1,,,,
LG2023_Control-2_intensity,,,,
NJH2024_Sub8_HIIT_Pre,,,,
KS2014_Intensity pY_N2,,,,
RB2022_5_RecoverySprint,,0.5191175758157713,,
RB2022_7_RecoverySprint,,0.5348763338839847,,
YA2020_Reporter_intensity_Normal_No.3,,,,
HS2024_8_B_T2,,,,
AH2018_LFQ_1_X,,,,
RM2024_Intensity D6-1___1,,,,
RCJD2014_10min_2,,,,
FR2021_Norm.Intensity.M,,,,
RM2024_Intensity D0-3___1,,,,
KS2014_Intensity N2,,,,
HH2022_Reporter intensity 1,,,,
HH2022_Reporter intensity 2,,,,
RM2024_Intensity D6-2___2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,,
RM2024_Intensity D2-3___2,,,,
YA2020_Reporter_intensity_Normal_No.5,,,,
SR2019_MCF7_Biol_repl_1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,,
HS2024_8_B_T1,,,,
NJH2025_Sub6_HIIT_Pre,,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,,
EP2017_Untreated R#2 log2 ratio,,0.5112825254398905,,
SR2019_LM2_Biol_repl_3,,,,
RB2022_4_RecoveryStrength,,0.5281193002342547,,
CR2017_Ratio Replicate 2,,,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,,
FSO2013_Ratio H/M normalized Rep3,,,,
AR2021_KD 72h,,,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,,
KBE2022_Log2_Ex_18_U,,,,
AS2011_Ratio H/L Inhi_1_1,,,,
NJH2024_Sub8_MICT_Post,,,,
AH2018_TMTMS3_3_C,,,,
KBE2022_Log2_Ex_9_U,,,,
AH2018_SILAC_M_3_N,,,,
KBE2022_Log2_Ex_13_T,,,,
RM2024_Intensity D0-3,,,,
SR2019_SKBR3_Biol_repl_1,,,,
PG2020_Intensity Mock_10h_C,,,,
CF2017_OSE 29,,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,,
NJH2025_Sub1_HIIT_Post,,,,
DL2023_24h-2,,,,
HS2024_7_B_N2,,,,
PG2020_Intensity 10h_A,,,,
RN2012_L12,,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,,
NJH2024_Sub8_MICT_Mid,,,,
AH2018_LFQ_IT_4_C,,,,
SAS2015_PLX/AZD_Exp1,,,,
FR2021_Norm.Intensity.A,,,,
FSO2013_Ratio H/M normalized Rep1___1,,,,
JW2015_Intensity cap2,,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,,
NJH2024_Sub6_MICT_Post,,,,
CK2022_8 40-1,,,,
RB2022_7_RecoveryEndurance,,0.4932043052632834,,
NJH2025_Sub12_HIIT_Post,,,,
EJN2021_4_Ex_Basal,,0.5150137914987366,0.4356853354354167,
TM2022_S2.12h.B,,,,
RN2012_L15,0.4272668061452922,,,
KS2014_Intensity pY_PV3,,,,
TM2022_S2.4h.B,,,,
PG2020_Intensity 4h_A,,,,
FSO2013_Ratio H/M normalized Rep2___2,,,,
TM2022_mock.4h.B,,,,
KBE2022_Log2_Ex_24_U,,,,
NJH2025_Sub13_MICT_Mid,,,,
KS2014_Intensity C3,,,,
RB2022_1_PreSprint,,0.498469549969781,,
HS2024_4_I_N1,,,,
CK2022_7 200-1,,,,
CK2022_5 200-1,,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,,
FSO2013_Ratio H/L normalized Rep2___1,,,,
NJH2024_Sub10_HIIT_Mid,,,,
RB2022_2_PostEndurance,,0.5336227588728679,,
AH2018_LFQ_2_C,,,,
AH2018_SILAC_MR_1_X,,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,,
IMM2018_normalised rep. int. Empty-2,,,,
RM2024_Intensity D4-1,,,,
KBE2022_Log2_Ex_25_U,,,,
AH2018_SILAC_3_C,,,,
EJN2021_5_Rest_Ins,,0.5267555238481829,0.4108976358368611,
VOI2024_0.1uM 24 h_3 di,,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,,
DB2022_LFQ intensity L2.1,,,,
FSO2013_Ratio H/M normalized Rep1,,,,
CK2022_4 16-1,,,,
AS2011_Ratio H/L,,,,
SR2019_MCF7_Biol_repl_4,,,,
EJN2021_2_Ex_Ins,,0.5280575378381318,0.44558991290435346,
AS2011_Ratio H/L Inhi_2_3,,,,
JAW2011_Ratio H/L LS1a_1,,,,
AH2018_LFQ_1_N,,,,
SAS2015_PLX/DMSO_Exp1,,,,
SFR2015_HL_log2_ratio_avg_c,,,,
JJ2018_Ratio M/L normalized pP2,,,,
NJH2024_Sub7_MICT_Mid,,,,
PG2020_Intensity 6h_B,,,,
FSO2013_Ratio H/L normalized Rep3,,,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,,
JJ2018_Ratio M/L normalized,,,,
KTGR2014_Ratio-AA 30 mins,,,,
JW2021_After_1,,,,
NJH2025_Sub2_MICT_Mid,,,,
HS2024_6_B_N2,,,,
KBE2022_Log2_Ex_9_T,,,,
AH2018_SILAC_IT_2_N,,,,
AH2018_SILAC_IT_1_X,,,,
HW2015_Ratio H/L normalized Exp3,,,,
HS2024_7_PD_T1,,,,
UK2020_UA_2,,,,
RM2024_Intensity D2-1___1,,,,
GF2025_P10_Sph,,,,
WZ2023_Pe_025_20min,,,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,,
AH2018_LFQ_2_N,,,,
HS2024_4_I_N2,,,,
AH2018_TMTMS2_3_N,,,,
RN2012_H06,0.5076024729182576,,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,,
HS2024_4_PD_T3,,,,
WZ2023_Su_005_30min,,,,
SR2019_HCC1419_Biol_repl_4,,,,
JJ2018_Ratio H/M normalized___2,,,,
SR2019_JIMT1_Biol_repl_3,,,,
AS2011_Ratio H/L Protein,,,,
UK2020_HCM_3,,,,
NJH2024_Sub10_HIIT_Post,,,,
CR2017_Ratio Replicate 3.1,,,,
WZ2023_Su_025_10min,,,,
AH2018_LFQ_IT_4_X,,,,
CP2009_Ratio H/L,,,,
VOI2024_0.1uM 24 h_3 mono,,,,
RB2022_4_RecoverySprint,,0.5519192932199839,,
RM2024_Intensity D6-3,,,,
WZ2023_Su_005_20min,,,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,,
SFR2015_HL_log2_ratio_avg_a,,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,,
RB2022_1_PreEndurance,,0.5171169089748975,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,,
LG2023_GSK3α-2_intensity,,,,
EP2017_Pervanadate R#1 log2 ratio,,0.5110955807548543,,
NJH2025_Sub6_HIIT_Post,,,,
RB2022_6_RecoverySprint,,0.5290102402890562,,
KS2014_Intensity,,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,,
PG2020_Intensity 8h_D,,,,
LY2019_P7+,,0.4866593652955069,,
EP2017_Untreated R#1 normalized log2 ratio,,0.5439400786036568,,
RN2012_L10,,,,
PG2020_Intensity 4h_C,,,,
EP2017_Mitotic R#3 normalized log2 ratio,,0.5365504827210822,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,,
DB2022_LFQ intensity L1,,,,
KBE2022_Log2_Ex_24_T,,,,
RB2022_8_PostStrength,,,,
AH2018_SILAC_IT_2_X,,,,
HS2024_4_B_T3,,,,
NJH2024_Sub2_HIIT_Post,,,,
HS2024_8_B_N2,,,,
NJH2025_Sub8_HIIT_Pre,,,,
JJ2018_Ratio H/L normalized pP2___1,,,,
HS2024_8_I_T2,,,,
KBE2022_Log2_Ex_6_U,,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,,
CR2017_Ratio Replicate 1.1,,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,,
CK2022_16 200-1,,,,
VOI2024_0.1uM 2 h_3 di,,,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.52566879142408,,
GF2025_P9_Sph,,,,
CK2022_6 200-1,,,,
NJH2024_Sub7_MICT_Post,,,,
AH2018_TMTMS3_2_X,,,,
NJH2024_Sub8_HIIT_Post,,,,
DB2022_LFQ intensity R1,,,,
JW2015_Intensity cap3,,,,
SR2019_HCC1954_Biol_repl_1,,,,
HS2024_4_I_T2,,,,
NJH2024_Sub2_MICT_Mid,,,,
VOI2024_0.1uM 2 h_2 mono,,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,,
HS2024_4_PD_T1,,,,
SAS2015_AZD/DMSO_Exp1,,,,
NJH2024_Sub1_MICT_Mid,,,,
IMM2018_normalised rep. int. CDK5L-3,,,,
HS2024_3_B_T3,,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,,
NJH2025_Sub13_MICT_Pre,,,,
SR2019_MDAMB231_Biol_repl_3,,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,,
MM2018_Ratio H/L replicate1,,,,
PG2020_Intensity 2h_D,,,,
EP2017_Untreated R#3 normalized log2 ratio,,0.5585851927476351,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,,
NJH2024_Sub7_HIIT_Pre,,,,
JAW2011_Ratio H/L LS2,,,,
CK2022_8 200-1,,,,
KS2014_Intensity pY_C4,,,,
CR2017_Ratio Replicate 3.5,,,,
RB2022_7_PostEndurance,,0.5438873029867269,,
NJH2025_Sub4_HIIT_Pre,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,,
TM2022_mock.12h.A,,,,
JJ2018_Ratio H/L normalized pP1,,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5232223015335769,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,,
KS2014_Intensity pY_E5_4,,,,
RM2024_Intensity D4-3___2,,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,,
AH2018_SILAC_2_C,,,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,,
HS2024_7_I_N1,,,,
KBE2022_Log2_Ex_29_T,,,,
HS2024_7_I_T2,,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,,
HS2024_6_B_T2,,,,
AMK2021_45I_p5,,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,,
SAS2015_PLX/DMSO_Exp2,,,,
EJN2021_1_Ex_Basal,,0.5182399755144842,0.4307187150354477,
FR2021_Intensity.M,,,,
RB2022_2_PostSprint,,0.5350446895699974,,
AH2018_SILAC_MR_3_N,,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,,
CF2017_FTE 13,,,,
PG2020_Intensity CT_C,,,,
ZCP2016_Ratio H/L Rep 1,,,,
FS2019_db/db2,,,,
KS2014_Intensity pY_PV4,,,,
KBE2022_Log2_Ex_39_U,,,,
EP2017_Untreated R#3 log2 ratio,,0.5575440562655279,,
RB2022_2_PostStrength,,0.5129688135624857,,
AS2011_Ratio H/L Normalized_1,,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,,
CR2017_Ratio Replicate 3.4,,,,
HS2024_8_PD_T2,,,,
FS2019_Ctr2,,,,
RB2022_6_PreEndurance,,0.5406115491510375,,
FR2021_Norm.Intensity.G,,,,
NJH2025_Sub9_HIIT_Post,,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,,
RM2024_Intensity D4-3,,,,
HS2024_8_B_N1,,,,
NJH2025_Sub10_MICT_Mid,,,,
KBE2022_Log2_Ex_15_U,,,,
AS2011_Ratio H/L Normalized Inhi_2,,,,
RKK2015_TNF-α/SC-514,,,,
RB2022_3_PreSprint,,0.5255827067577293,,
CR2017_Ratio Replicate 2.3,,,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,,
GF2025_P4_Adh,,,,
YA2020_Reporter_intensity_Normal_No.2,,,,
YP2020_Intensity P30_R2_mult_log2,,,,
NJH2025_Sub13_MICT_Post,,,,
HS2024_4_B_N2,,,,
HS2024_3_PD_T3,,,,
AMK2021_120R_p3,,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,,
NJH2025_Sub10_HIIT_Pre,,,,
FR2021_Intensity.G,,,,
RAM2015_Log2 C,,,,
AS2011_Ratio H/L Proteins Inhi_1,,,,
FSO2013_Ratio H/M normalized Rep1___3,,,,
AH2018_LFQ_M_2_N,,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,,
KBE2022_Log2_Ex_40_T,,,,
CK2022_2 16-1,,,,
RAM2015_Log2 B,,,,
YP2020_Intensity C10_R1_mult_log2,,,,
FSO2013_Ratio M/L normalized Rep1___2,,,,
NJH2025_Sub8_MICT_Pre,,,,
EJN2021_4_Rest_Basal,,0.5281126476278609,0.42213119149548894,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,,
JJ2018_Ratio H/M normalized pP3___1,,,,
VOI2024_Veh2 mono,,,,
HS2024_6_B_T1,,,,
UK2020_HCM_5,,,,
NJH2025_Sub10_HIIT_Post,,,,
VOI2024_0.1uM 2 h_3 mono,,,,
JW2015_Intensity pre3,,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,,
DL2023_24h-3,,,,
HS2024_7_PD_T3,,,,
PG2020_Intensity Mock_10h_B,,,,
WZ2023_Su_025_30min,,,,
AH2018_LFQ_4_N,,,,
CR2017_Ratio Replicate 1.2,,,,
AS2011_Ratio H/L Normalized by Proteins,,,,
RB2022_6_RecoveryStrength,,0.5171208315646598,,
HS2024_8_I_N1,,,,
AMK2021_Ctrl_p3,,,,
AS2011_Ratio H/L Protein Inhi_2,,,,
HH2022_Reporter intensity 7,,,,
AH2018_SILAC_M_1_X,,,,
RB2022_7_PreEndurance,,0.505216875644239,,
VOI2024_0.1uM 24 h_2 di,,,,
DL2023_control-2,,,,
LY2019_P6+,,0.5232151905726617,,
DB2022_LFQ intensity R2,,,,
GF2025_P6_Adh,,,,
VOI2024_Veh1 di,,,,
AS2011_Ratio H/L RNAi_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,,
VOI2024_Veh3 mono,,,,
HS2024_5_I_T2,,,,
NJH2025_Sub7_HIIT_Mid,,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,,
RB2022_6_PostSprint,,0.524699781702901,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,,
AS2011_Ratio H/L Inhi_1,,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,,
AH2018_TMTMS3_2_C,,,,
SR2019_Hs578T_Biol_repl_4,,,,
RB2022_8_PreStrength,,0.5246982917866114,,
KS2014_Intensity C5,,,,
RM2024_Intensity D0-1,,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,,
YP2020_Intensity P30_R1_mult_log2,,,,
NJH2025_Sub2_HIIT_Pre,,,,
RB2022_3_RecoveryEndurance,,0.5065881793029395,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,,
GF2025_P9_Adh,,,,
RB2022_3_PostStrength,,0.5269276282393545,,
TM2022_S2.8h.A,,,,
AS2011_Ratio H/L RNAi_1_1,,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,,
NJH2025_Sub2_MICT_Pre,,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,,
HS2024_4_B_T2,,,,
SR2019_BT549_Biol_repl_1,,,,
AH2018_LFQ_M_4_N,,,,
NJH2024_Sub8_HIIT_Mid,,,,
PG2020_Intensity 8h_B,,,,
AH2018_LFQ_2_X,,,,
PG2020_Intensity 2h_B,,,,
AS2011_Ratio H/L Proteins RNAi_1,,,,
RB2022_4_PostSprint,,0.5241405594169688,,
KS2014_Intensity E15_3,,,,
GF2025_P3_Sph,,,,
DB2022_LFQ intensity L2,,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,,
AH2018_SILAC_1_C,,,,
NJH2024_Sub1_HIIT_Pre,,,,
FSO2013_Ratio M/L normalized Rep2___2,,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,,0.5841862177006802
AS2011_Ratio H/L RNAi_2_3,,,,
AH2018_SILAC_IT_1_N,,,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,,
RB2022_4_PreEndurance,,0.49886662587027397,,
JJ2018_Ratio M/L normalized pP1,,,,
CR2017_Ratio Replicate 2.4,,,,
ZQ2022_N1,,0.5474590239943262,0.49384050999807805,
LY2019_P6-,,0.5203534406180822,,
RM2024_Intensity D2-3,,,,
UK2020_HCM_1,,,,
JW2015_Intensity pre2,,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,,
RM2024_Intensity D2-1,,,,
NJH2025_Sub12_MICT_Post,,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,,
RN2012_L14,0.47317179366461415,,,
AH2018_LFQ_3_N,,,,
RKK2015_TNF-α/IKKb,,,,
SFR2015_HL_log2_ratio_std_b,,,,
UK2020_UA_1,,,,
KBE2022_Log2_Ex_13_U,,,,
AS2011_Ratio H/L Normalized Inhi_1,,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,,
RB2022_1_RecoverySprint,,0.5366399082612234,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,,
JJ2018_Ratio H/L normalized pP3,,,,
CK2022_7 40-1,,,,
AS2011_Ratio H/L Inhi_1_3,,,,
NJH2025_Sub10_HIIT_Mid,,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,,
JAW2011_Ratio H/L LS1b_1,,,,
PG2020_Intensity 4h_B,,,,
SR2019_BT549_Biol_repl_2,,,,
RM2024_Intensity D4-2,,,,
DB2022_LFQ intensity R2.2,,,,
JJ2018_Ratio H/L normalized,,,,
RB2022_5_PostEndurance,,0.5554996484561141,,
HS2024_5_PD_T2,,,,
WZ2023_Su_025_20min,,,,
RM2024_Intensity D2-2___1,,,,
IMM2018_normalised rep. int. CDK5L-2,,,,
LY2019_P8-,,0.5265861090156225,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,,
FSO2013_Ratio H/L normalized Rep1,,,,
NJH2024_Sub2_HIIT_Pre,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,,
CK2022_13 40-1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,,
RN2012_H02,,,,
PG2020_Intensity 10h_D,,,,
RB2022_8_PreEndurance,,0.5165113179962072,,
HS2024_3_B_N2,,,,
EJN2021_4_Ex_Ins,,0.5203733571590021,0.4400284292075183,
AS2011_Ratio H/L Normalized by Protein,,,,
EJN2021_1_Ex_Ins,,0.5213318945968676,0.41990514565470477,
EP2017_Pervanadate R#3 log2 ratio,,0.504530899025151,,
FSO2013_Ratio M/L normalized Rep1___3,,,,
NJH2025_Sub4_HIIT_Mid,,,,
RCJD2014_5min_2,,,,
RB2022_6_PostStrength,,,,
AH2018_SILAC_MR_3_C,,,,
AH2018_LFQ_M_4_C,,,,
NJH2024_Sub4_MICT_Pre,,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,,
DL2023_12h-1,,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,,
DB2022_LFQ intensity L1.1,,,,
NJH2025_Sub6_MICT_Pre,,,,
NJH2025_Sub6_MICT_Post,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,,
RN2012_H04,0.49282598978046677,,,
CK2022_6 40-1,,,,
DB2022_LFQ intensity R2.1,,,,
KBE2022_Log2_Ex_42_U,,,,
LY2019_P3-,,0.5268856185205137,,
FR2021_Intensity.A,,,,
EJN2021_3_Ex_Ins,,0.5252447645776457,0.42298498573309373,
MV2014_Ratio M/L normalized A1___1 (2 min),,,,
WZ2023_Pe_005_30min,,,,
HS2024_8_PD_T3,,,,
EJN2021_3_Ex_Basal,,0.5111908500041757,0.431446076058998,
AST2020_Control.1,,,,
JW2015_Intensity cap1,,,,
PG2020_Intensity CT_A,,,,
FS2019_Ctr3,,,,
WZ2023_Pu_025_20min,,,,
NJH2025_Sub4_MICT_Post,,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,,
GF2025_P10_Adh,,,,
RB2022_1_RecoveryStrength,,0.5051574434062125,,
SR2019_HCC1954_Biol_repl_4,,,,
FR2021_Norm.Intensity.N,,,,
HS2024_5_B_N1,,,,
FSO2013_Ratio H/M normalized Rep3___3,,,,
AH2018_TMTMS2_2_C,,,,
RB2022_4_PreSprint,,0.5097866388117032,,
DB2022_Intensity R2,,,,
AH2018_TMTMS2_Pool,,,,
HS2024_8_I_N2,,,,
RB2022_3_RecoveryStrength,,0.5150796936794607,,
NJH2024_Sub6_HIIT_Mid,,,,
AH2018_SILAC_M_1_C,,,,
LY2019_P8+,,0.5319882969487688,,
RB2022_2_RecoveryEndurance,,0.5064034411929578,,
JJ2018_Ratio H/M normalized pP2___1,,,,
JAW2011_Ratio H/L HS_1,,,,
RB2022_3_PostEndurance,,0.53990895792973,,
KS2014_Intensity pY_PV1,,,,
JAW2011_Ratio H/L LS1b_2,,,,
SR2019_MCF7_Biol_repl_2,,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,,0.6053842991320602
AS2011_Ratio H/L Normalized RNAi_1_1,,,,
AH2018_LFQ_M_4_X,,,,
NJH2024_Sub6_MICT_Pre,,,,
JJ2018_Ratio M/L normalized pP1___2,,,,
YP2020_Intensity C30_R2_mult_log2,,,,
NJH2024_Sub9_HIIT_Pre,,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,,
RM2024_Intensity D0-1___3,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,,
KBE2022_Log2_Ex_28_U,,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,,
CF2017_FTE 17,,,,
LY2019_P2-,,0.5373363386822466,,
AH2018_LFQ_IT_1_X,,,,
JJ2018_Ratio H/L normalized pP3___1,,,,
RB2022_8_RecoveryStrength,,0.5194336437542699,,
WZ2023_Pe_005_20min,,,,
AST2020_Control.2,,,,
NJH2025_Sub6_MICT_Mid,,,,
RCJD2014_10min_1,,,,
FSO2013_Ratio H/L normalized Rep2___3,,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,,
HS2024_3_I_T1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,,
CK2022_4 40-1,,,,
SR2019_MCF10A_Biol_repl_4,,,,
KS2014_Intensity pY_C5,,,,
NJH2025_Sub4_MICT_Pre,,,,
NJH2024_Sub9_MICT_Post,,,,
CF2017_OSE 28,,,,
HS2024_5_B_T2,,,,
HS2024_6_I_T1,,,,
HS2024_5_B_T3,,,,
JJ2018_Ratio H/M normalized pP1___1,,,,
KBE2022_Log2_Ex_36_U,,,,
AH2018_TMTMS3_3_N,,,,
SR2019_HCC1419_Biol_repl_2,,,,
FR2021_Intensity.N,,,,
AS2011_Ratio H/L Inhi_2_1,,,,
AH2018_SILAC_MR_1_C,,,,
NJH2024_Sub1_HIIT_Mid,,,,
NJH2025_Sub8_HIIT_Mid,,,,
EP2017_Mitotic R#3 log2 ratio,,0.5413258589049161,,
KBE2022_Log2_Ex_36_T,,,,
NJH2025_Sub6_HIIT_Mid,,,,
WZ2023_Pu_005_30min,,,,
KS2014_Intensity C2,,,,
FSO2013_Ratio H/L normalized Rep1___2,,,,
RM2024_Intensity D2-2,,,,
KBE2022_Log2_Ex_42_T,,,,
CK2022_9 200-1,,,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,,
JJ2018_Ratio H/M normalized pP3___2,,,,
DB2022_LFQ intensity R1.1,,,,
CK2022_10 200-1,,,,
NJH2024_Sub9_MICT_Mid,,,,
JAW2011_Ratio H/L_2,,,,
HS2024_7_I_N2,,,,
RBK2021_1332T Late,,,,
LY2019_P1-,,0.5291667961273496,,
RKK2015_TNF-α/basal.1,,,,
RKK2015_TNF-α/TNF-α+SC-514,,,,
CR2017_Ratio Replicate 2.5,,,,
HS2024_3_I_T3,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,,
AS2011_Ratio H/L Normalized RNAi_1,,,,
KS2014_Intensity E15_4,,,,
ZQ2022_C3,,0.5027662561730575,0.5486712122676687,
EJN2021_3_Rest_Ins,,0.531241132139554,0.44159772405680625,
YP2020_Intensity P10_R2_mult_log2,,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,,
NJH2025_Sub1_MICT_Pre,,,,
KBE2022_Log2_Ex_39_T,,,,
FSO2013_Ratio H/M normalized Rep3___2,,,,
RM2024_Intensity D6-2,,,,
EP2017_Untreated R#1 log2 ratio,,0.5428818132466577,,
RKK2015_SC-514/basal,,,,
RM2024_Intensity D6-1___3,,,,
WZ2023_Pu_010_10min,,,,
NJH2025_Sub9_HIIT_Mid,,,,
SR2019_SKBR3_Biol_repl_4,,,,
HS2024_5_I_T3,,,,
KS2014_Intensity N1,,,,
NJH2024_Sub12_MICT_Post,,,,
TM2022_S2.8h.C,,,,
CR2017_Ratio Replicate 1,,,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,,
JJ2018_Ratio H/M normalized pP3,,,,
AH2018_SILAC_MR_2_C,,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,,
PG2020_Intensity 2h_A,,,,
NJH2024_Sub6_MICT_Mid,,,,
NJH2025_Sub13_HIIT_Post,,,,
AH2018_SILAC_MR_3_X,,,,
JJ2018_Ratio H/M normalized___1,,,,
RCJD2014_15min_2,,,,
AS2011_Ratio H/L_2,,,,
AS2011_Ratio H/L Normalized,,,,
RN2012_H03,0.4887519372989313,,,
HS2024_5_B_N2,,,,
HS2024_5_I_N1,,,,
HS2024_6_I_N1,,,,
AR2021_KD 48h,,,,
FR2021_Intensity.B,,,,
RB2022_3_PreEndurance,,0.5248268411831338,,
HS2024_5_I_T1,,,,
NJH2024_Sub10_MICT_Pre,,,,
SR2019_LM2_Biol_repl_2,,,,
AST2020_anti-CD3,,,,
SR2019_MDAMB231_Biol_repl_1,,,,
RM2024_Intensity D2-3___3,,,,
WZ2023_Pe_005_10min,,,,
KBE2022_Log2_Ex_29_U,,,,
HS2024_7_B_T1,,,,
AH2018_LFQ_M_2_X,,,,
AH2018_LFQ_IT_4_N,,,,
CK2022_15 200-1,,,,
RM2024_Intensity D4-1___2,,,,
JJ2018_Ratio H/M normalized,,,,
JJ2018_Ratio M/L normalized pP3___1,,,,
KBE2022_Log2_Ex_34_T,,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,,
LY2019_P2+,,0.49175911566947894,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,,
CK2022_2 200-1,,,,
AS2011_Ratio H/L Protein RNAi_2,,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,,
WZ2023_Su_010_30min,,,,
RN2012_H01,,,,
KTGR2014_Ratio-Rapa 2 mins,,,,
EJN2021_2_Rest_Basal,,0.5242020821138524,0.4424257390584114,
KS2014_Intensity pY_E5_3,,,,
MM2018_Ratio H/L replicate 3,,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5107248038478205,,
HS2024_8_B_T3,,,,
YA2020_Reporter_intensity_Cancer_No.3,,,,
KBE2022_Log2_Ex_44_U,,,,
WZ2023_Pe_010_20min,,,,
KS2014_Intensity pY_C6,,,,
AS2011_Ratio H/L Normalized_3,,,,
RCJD2014_15min_mean,,,,
RB2022_3_PreStrength,,0.5279461053679246,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,,
RCJD2014_10min_mean,,,,
KS2014_Intensity C1,,,,
FSO2013_Ratio H/M normalized Rep3___1,,,,
AH2018_SILAC_M_3_C,,,,
RKK2015_TNF-α+IKKb/TNF-α,,,,
RM2024_Intensity D0-3___2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,,
AH2018_SILAC_M_2_C,,,,
AH2018_SILAC_M_2_X,,,,
KTGR2014_Ratio-Rapa 15 mins,,,,
RM2024_Intensity D4-2___1,,,,
KBE2022_Log2_Ex_15_T,,,,
VOI2024_0.1uM 24 h_1 di,,,,
WZ2023_Su_010_10min,,,,
PG2020_Intensity 6h_C,,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,,
JJ2018_Ratio M/L normalized pP1___1,,,,
AH2018_LFQ_M_3_N,,,,
VOI2024_0.1uM 24 h_2 mono,,,,
AH2018_TMTMS2_3_C,,,,
CK2022_15 16-1,,,,
CK2022_3 16-1,,,,
LY2019_P4-,,0.5605489850853972,,
FSO2013_Ratio H/L normalized Rep3___2,,,,
KS2014_Intensity pY_PV2,,,,
HS2024_3_I_N2,,,,
GF2025_P8_Adh,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,,
GF2025_P5_Sph,,,,
CK2022_10 16-1,,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,,
VOI2024_0.1uM 2 h_2 di,,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,,0.533698934302399
NJH2024_Sub2_HIIT_Mid,,,,
AMK2021_45I_p3,,,,
NJH2024_Sub13_HIIT_Mid,,,,
DB2022_LFQ intensity R1.2,,,,
DB2022_Intensity R1,,,,
NJH2024_Sub12_MICT_Mid,,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,,
UK2020_HCM_4,,,,
SAS2015_AZD/DMSO_Exp2,,,,
IMM2018_normalised rep. int. CDK5L-1,,,,
DB2022_LFQ intensity L2.2,,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,,
EP2017_Mitotic R#1 log2 ratio,,0.5302666255921887,,
EJN2021_2_Ex_Basal,,0.5276135296608967,0.4336428365090264,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,,
KTGR2014_Ratio-Rapa 30 mins,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,,
CF2017_FTE 16,,,,
AR2021_L41 10 μM,,,,
CF2017_EOC 2,,,,
RB2022_6_PostEndurance,,0.542275181870516,,
AH2018_SILAC_1_N,,,,
NJH2024_Sub10_HIIT_Pre,,,,
AS2011_Ratio H/L Inhi_1_2,,,,
UK2020_HCM_6,,,,
RB2022_7_PreSprint,,0.5122916408875817,,
NJH2024_Sub2_MICT_Pre,,,,
HS2024_3_PD_T2,,,,
CK2022_6 16-1,,,,
ZX2022_CB treated Replicate 1,,,0.34726710372800607,
BS2014_Log2(Ratio H/L normalized Rep_3),,,,
TM2022_mock.12h.C,,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,,
HH2022_Reporter intensity 0,,,,
RM2024_Intensity D2-2___2,,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,,
RB2022_1_PreStrength,,0.5182012655697859,,
JJ2018_Ratio H/M normalized pP2___2,,,,
AH2018_TMTMS2_2_X,,,,
AR2021_L41 1 μM,,,,
JJ2018_Ratio H/M normalized pP1___2,,,,
AH2018_TMTMS2_1_N,,,,
NJH2025_Sub10_MICT_Pre,,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,,
ZX2022_Control Replicate 3,,,0.3840898020826676,
KS2014_Intensity C4,,,,
AS2011_Ratio H/L Inhi_2,,,,
KBE2022_Log2_Ex_18_T,,,,
NJH2025_Sub9_MICT_Pre,,,,
RCJD2014_20min_1,,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,,
FSO2013_Ratio M/L normalized Rep2___3,,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,,
SR2019_MCF10A_Biol_repl_3,,,,
HS2024_7_B_T2,,,,
SAS2015_PLX/DMSO_Exp3,,,,
AMK2021_Ctrl_p5,,,,
NJH2025_Sub2_HIIT_Mid,,,,
AH2018_LFQ_M_3_C,,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,,
YA2020_Reporter_intensity_Cancer_No.2,,,,
FSO2013_Ratio H/M normalized Rep2___3,,,,
RB2022_8_PreSprint,,0.5231542123154103,,
AH2018_SILAC_IT_3_C,,,,
WZ2023_Pu_025_10min,,,,
RM2024_Intensity D2-2___3,,,,
AS2011_Ratio H/L_1,,,,
RCJD2014_10min_3,,,,
FSO2013_Ratio M/L normalized Rep3___1,,,,
SR2019_JIMT1_Biol_repl_4,,,,
YP2020_Intensity C10_R2_mult_log2,,,,
ZCP2016_Ratio H/L Rep 2,,,,
CF2017_EOC 4,,,,
JJ2018_Ratio H/L normalized pP1___1,,,,
WZ2023_Pe_010_30min,,,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,,
AH2018_LFQ_IT_3_N,,,,
KS2014_Intensity C6,,,,
ZQ2022_N3,,0.5553497956759701,0.4637546009022063,
HW2015_Ratio H/L normalized Exp1,,,,
CK2022_12 40-1,,,,
NJH2024_Sub7_MICT_Pre,,,,
ZX2022_Control Replicate 1,,,0.3855517757369261,
JJ2018_Ratio H/M normalized pP1,,,,
CK2022_16 40-1,,,,
AH2018_SILAC_IT_2_C,,,,
CK2022_5 40-1,,,,
AH2018_LFQ_3_X,,,,
UK2020_UA_3,,,,
LY2019_P7-,,0.4842046352376537,,
GF2025_P5_Adh,,,,
RB2022_1_PostStrength,,0.5235413758969527,,
JAW2011_Ratio H/L LS1b,,,,
FSO2013_Ratio H/L normalized Rep3___1,,,,
SR2019_HCC1954_Biol_repl_3,,,,
CR2017_Ratio Replicate 2.2,,,,
VOI2024_0.1uM 2 h_1 mono,,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,,
CK2022_11 16-1,,,,
ZQ2022_C1,,0.49454510367835425,0.45512741167114357,
CR2017_Ratio Replicate 2.1,,,,
PG2020_Intensity CT_B,,,,
JJ2018_Ratio M/L normalized___2,,,,
AH2018_SILAC_MR_1_N,,,,
KS2014_Intensity pY_E5_1,,,,
JW2021_Before_3,,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,,
FS2019_db/db1,,,,
NJH2025_Sub9_HIIT_Pre,,,,
JAW2011_Ratio H/L_1,,,,
RCJD2014_20min_3,,,,
AH2018_LFQ_3_C,,,,
JJ2018_Ratio M/L normalized pP3___2,,,,
AMK2021_45I_p1,,,,
NJH2025_Sub8_HIIT_Post,,,,
AH2018_LFQ_M_3_X,,,,
YA2020_Reporter_intensity_Cancer_No.4,,,,
KS2014_Intensity pY_E5_2,,,,
FSO2013_Ratio H/L normalized Rep1___3,,,,
GF2025_P4_Sph,,,,
RB2022_2_PreEndurance,,0.5243492422216939,,
JW2021_Before_1,,,,
KBE2022_Log2_Ex_25_T,,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,,
JJ2018_Ratio M/L normalized___1,,,,
FR2021_Intensity.H,,,,
CK2022_14 16-1,,,,
AST2020_anti-CD3+PDL2,,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,,
KBE2022_Log2_Ex_19_T,,,,
KS2014_Intensity pY_N1,,,,
RB2022_1_RecoveryEndurance,,0.5181881961492126,,
FSO2013_Ratio H/M normalized Rep1___2,,,,
HS2024_8_I_T1,,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,,
EP2017_Mitotic R#2 log2 ratio,,0.5254960489477273,,
AH2018_TMTMS2_1_X,,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,,
ZCP2016_Ratio H/L Rep 3,,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,,
SR2019_MCF10A_Biol_repl_1,,,,
NJH2025_Sub8_MICT_Mid,,,,
EJN2021_5_Ex_Ins,,0.5237215461997645,0.4372330181513633,
HS2024_6_I_N2,,,,
HH2022_Reporter intensity 4,,,,
RBK2021_1326T Late,,,,
TM2022_mock.12h.B,,,,
NJH2024_Sub12_MICT_Pre,,,,
RCJD2014_15min_3,,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,,
LG2023_Control-3_intensity,,,,
JJ2018_Ratio H/L normalized pP3___2,,,,
CF2017_FTE 15,,,,
HS2024_4_I_T3,,,,
AH2018_SILAC_1_X,,,,
PG2020_Intensity 10h_B,,,,
AH2018_TMTMS3_1_X,,,,
CF2017_FTE 14,,,,
NJH2024_Sub13_HIIT_Post,,,,
RM2024_Intensity D6-3___3,,,,
NJH2025_Sub7_HIIT_Pre,,,,
RBK2021_1259T Early,,,,
RKK2015_IKK+TNF-α/IKKb,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,,
PG2020_Intensity 6h_A,,,,
SR2019_HCC1419_Biol_repl_3,,,,
KBE2022_Log2_Ex_14_T,,,,
EP2017_Untreated R#2 normalized log2 ratio,,0.511845303923556,,
RM2024_Intensity D0-2___1,,,,
DB2022_Intensity L1,,,,
LY2019_P5+,,0.5246318725785876,,
HS2024_5_I_N2,,,,
SAS2015_PLX/AZD_Exp3,,,,
EP2017_Pervanadate R#2 log2 ratio,,0.5238681255166242,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,,
